These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S, Akhtar N, Ahmad J. Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [Abstract] [Full Text] [Related]
9. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome. Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M. J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810 [Abstract] [Full Text] [Related]
10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B, Mitkov M. Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [Abstract] [Full Text] [Related]
11. The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. Uncu G, Sözer MC, Develioğlu O, Cengiz C. Gynecol Endocrinol; 2002 Dec; 16(6):447-52. PubMed ID: 12626031 [Abstract] [Full Text] [Related]
12. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560 [Abstract] [Full Text] [Related]
13. Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. Wang Q, Guo T, Tao Y, Wang Q, Song Y, Huang W. Gynecol Endocrinol; 2011 Nov; 27(11):931-4. PubMed ID: 21495802 [Abstract] [Full Text] [Related]
15. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V, Nagamani M. J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [Abstract] [Full Text] [Related]
16. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [Abstract] [Full Text] [Related]
17. Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin. Cardoso NS, Ribeiro VB, Dutra SGV, Ferriani RA, Gastaldi AC, Araújo JE, Souza HCD. Arch Endocrinol Metab; 2020 Feb; 64(1):4-10. PubMed ID: 32187268 [Abstract] [Full Text] [Related]